Cyprium Therapeutics, Inc.
Biotechnology company · New York, United States
Cyprium Therapeutics, Inc. is a biotechnology company headquartered in New York, United States. It has reported private securities offerings to the US SEC, most recently $7 million sold in a notice filed in 2021.
Profile compiled from public records. Is this your company? Request a correction or update
Cyprium Therapeutics at a glance
Typebiotechnology company
HeadquartersNew York, United States
SEC CIK1890689
What does Cyprium Therapeutics do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $7 million sold (2021).
Frequently asked questions about Cyprium Therapeutics
Where is Cyprium Therapeutics headquartered?
Cyprium Therapeutics, Inc. is headquartered in New York, United States.
What does Cyprium Therapeutics do?
Cyprium Therapeutics, Inc. is a biotechnology company.
Similar companies
- Lexeo Therapeutics, Inc.New York City, New York, United States
- MiNK Therapeutics, Inc.New York City, New York, United States
- IN8BIO, Inc.New York City, New York, United States
- Anavex Life Sciences Corp.New York City, New York, United States
- Brainstorm Cell Therapeutics Inc.New York City, New York, United States
- Bioincept LLCNew York City, New York, United States
- Protara Therapeutics, Inc.New York City, New York, United States
- Ancilia Biosciences, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences